Skip to main content
. 2016 Apr 12;174(4):563–570. doi: 10.1111/bjh.14088

Figure 1.

Figure 1

Trial design. CHASE(R), cyclophosphamide, cytarabine, etoposide and dexamethasone ± rituximab.